Boldt: The great pretender

BMJ (Online)

Volumn 346, Issue 7900, 2013, Pages

  Wise, Jacqui ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HETASTARCH; INFUSION FLUID;

ACID BASE BALANCE; ANALGESIA; ANAPHYLACTIC SHOCK; ANESTHESIST; ARTICLE; BLEEDING; CLINICAL PRACTICE; CLINICAL RESEARCH; COLLOID; CRYSTALLOID; DOCUMENTATION; ETHNIC GROUP; EVIDENCE BASED PRACTICE; FLUID RESUSCITATION; GERMAN; HEART FAILURE; HEART SURGERY; HIGH RISK PATIENT; HUMAN; INFLAMMATION; INTENSIVE CARE; INVESTIGATIVE PROCEDURES; KIDNEY FAILURE; MEDICAL ETHICS; MEDICAL LITERATURE; MEDICAL SPECIALIST; MORTALITY; NANOFABRICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROFESSIONAL MISCONDUCT; PUBLICATION; PUMP; UNITED KINGDOM;

EID: 84875458427     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f1738     Document Type: Article

References (12)

1. Boldt J, Suttner S, Brosch C, Lehmann A, Röhm K, Mengistu A. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy [retracted]. Anesth Analg 2009;109:1752-62.
2. KLiLu. Investigation report of the commission for the press conference on 29 November 2010. www.klilu.de/content/veranstaltungen-presse/pressearchiv/ 2010/untersuchungsbericht-der-kommission-fuer-die-pressekonferenz-am-29- november-2010/index-ger.html?raw=Boldt&ZMS-HIGHLIGHT=raw.
3. Editors in chief statement regarding published clinical trials conducted without IRB approval by Joachim Boldt. 2011. www.aaeditor.org/EIC.Joint. Statement.on.Retractions.pdf
4. Ludwigshafen Hospital presents results of final report, press release, 9 August 2012. www.klilu.de/content/veranstaltungen-presse/pressearchiv/2012/ hospital-presents-results-of-final-report-committee-completes-investigation-in- the-case-of-dr-boldt/index-ger.html.
5. European Commission. Proposal for a regulation of the European parliament and of the Council on Clinical Trials on Medicinal Products for Human Use, and repealing directive2001/20/ec. http://ec.europa.eu/health/files/clinicaltrials/ 2012-07/proposal/2012-07-proposal-en.pdf
6. Schierhout, G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 1998;316:961-4. (Pubitemid 28135143)
7. Dyer C. Guidance on intravenous fluid therapy is to be reviewed after six quoted articles are withdrawn. BMJ 2011;342:d1492.
8. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2012;6:CD000567.
9. Zarychanski, R, Abou-Setta A, Turgeon A, Houston, B, McIntyre, L, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation a systematic review and meta-analysis. JAMA 2013;309:678-88.
10. Antonelli M, Sandroni C. Hydroxyethyl starch for intravenous volume replacement more harm than benefit. JAMA 2013;309:7234.
11. Haase, N, Perner A, Inkeri Hennings L, Siegmund M, Lauridson B Wetterslev M, et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 2013;346:f839.
12. Reinhart K, Perner A, Sprung CL, Jaeschke R, Schortgen F, Johan Groeneveld AB, et al. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 2012;38:368-83.